The second class of drugs approved to treat the cognitive symptoms of neurocognitive disorder regulate the activity of the neurotransmitter glutamate.
Glutamate is a dominant excitatory neurotransmitter this is launched with the aid of nerve cells inside the brain. It’s far liable for sending signals among nerve cells, and beneath normal conditions it performs a critical function in learning and memory.